| Akkaraju Srinivas |
Non-Executive Director |
ALUMIS INC. (ALMS)
|
2025-05-05 |
$4.61 |
0.0% |
320,290
|
$1,477,312 |
| Akkaraju Srinivas |
Non-Executive Director |
Mineralys Therapeutics, Inc. (MLYS)
|
2025-03-13 |
$13.50 |
0.0% |
600,000
|
$8,100,000 |
| Akkaraju Srinivas |
Non-Executive Director |
Syros Pharmaceuticals, Inc. (SYRS)
|
2023-12-21 |
$4.42 |
-65.4% |
904,977
|
$3,999,998 |
| Akkaraju Srinivas |
Non-Executive Director |
Scholar Rock Holding Corp (SRRK)
|
2023-10-16 |
$6.85 |
25.4% |
2,189,781
|
$15,000,000 |
| Akkaraju Srinivas |
Non-Executive Director |
Mineralys Therapeutics, Inc. (MLYS)
|
2023-02-14 |
$16.00 |
-25.4% |
937,500
|
$15,000,000 |
| Akkaraju Srinivas |
Non-Executive Director |
CHINOOK THERAPEUTICS, INC. (KDNY)
|
2022-05-27 |
$14.00 |
188.5% |
570,000
|
$7,980,000 |
| Akkaraju Srinivas |
Non-Executive Director |
CHINOOK THERAPEUTICS, INC. (KDNY)
|
2021-11-15 |
$14.00 |
188.5% |
1,215,000
|
$17,010,000 |
| Akkaraju Srinivas |
Non-Executive Director |
CHINOOK THERAPEUTICS, INC. (KDNY)
|
2021-08-18 |
$11.98 |
237.1% |
208,500
|
$2,497,830 |
| Akkaraju Srinivas |
Non-Executive Director |
INTERCEPT PHARMACEUTICALS, INC. (ICPT)
|
2021-03-12 |
$21.17 |
-10.2% |
237,000
|
$5,016,252 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
65.6% |
$49,904,966 |
$76,081,393 |